Attached files
| file | filename |
|---|---|
| EX-32.2 - CERTIFICATION - Mawson Infrastructure Group Inc. | f10q0620ex32-2_wize.htm |
| EX-31.2 - CERTIFICATION - Mawson Infrastructure Group Inc. | f10q0620ex31-2_wize.htm |
| EX-31.1 - CERTIFICATION - Mawson Infrastructure Group Inc. | f10q0620ex31-1_wize.htm |
| EX-10.2 - AMENDMENT TO LETTER AGREEMENT (SPA), DATED JULY 1, 2020, BY AND BETWEEN THE COMP - Mawson Infrastructure Group Inc. | f10q0620ex10-2_wize.htm |
| EX-10.1 - LETTER AGREEMENT (SPA), DATED JUNE 24, 2020, BY AND BETWEEN THE COMPANY AND BONU - Mawson Infrastructure Group Inc. | f10q0620ex10-1_wize.htm |
| 10-Q - QUARTERLY REPORT - Mawson Infrastructure Group Inc. | f10q0620_wizepharma.htm |
EXHIBIT 32.1
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350
AS ADOPTED PURSUANT TO SECTION 906
OF THE SARBANES-OXLEY ACT OF 2002
I, Noam Danenberg, Chief Executive Officer of Wize Pharma, Inc. (Company), do hereby certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to the best of my knowledge:
| ● | the Quarterly Report on Form 10-Q of the Company for the quarter ended June 30, 2020 (Report) fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and |
| ● | the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company for the periods presented therein. |
| Date: August 14, 2020 | |
| /s/ Noam Danenberg | |
| Noam Danenberg | |
| Chief Executive Officer | |
| (Principal Executive Officer) |